U.S. Wireless Telecom Stock News

NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health (CLOV) Quarterly Profit Challenges Longstanding Bearish Loss Narratives

Clover Health Investments (CLOV) opened Q1 2026 with revenue of US$749.2 million and basic EPS of US$0.05, alongside net income excluding extra items of US$27.3 million, giving investors a clean read on the core business. Over the last five reported quarters, revenue has moved from US$336.9 million in Q4 2024 to US$749.2 million in Q1 2026, while quarterly basic EPS has shifted from a loss of US$0.04 to a profit of US$0.05. This sets up this update as a key check on whether those improving...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Is It Time To Reassess Vertex (VRTX) After Recent Share Price Weakness?

If you are wondering whether Vertex Pharmaceuticals at around US$425 per share offers good value or is already pricing in too much optimism, this article breaks down what the current stock price may be implying. The stock is around US$425 after a 0.6% slip over the last week, a 1.6% decline over the last month and a 6.0% decline year to date. The 1 year return sits at 1.1%, the 3 year at 21.3% and the 5 year at 98.3%. Recent attention around Vertex has focused on its product pipeline and...
NYSE:COR
NYSE:CORHealthcare

Cencora (COR) Q2 2026 EPS Surge Tests Bullish Earnings Growth Narratives

Cencora (COR) has put up a busy Q2 2026, with revenue of about US$78.4b, basic EPS of US$8.44 and net income of US$1,641.3m setting the tone for this earnings season update. Over the past six reported quarters, revenue has moved between roughly US$75.5b and US$86.0b while quarterly EPS has ranged from a loss of US$1.75 to a high of US$8.44. This gives investors a clear view of how the earnings line has tracked alongside a very large top line. Taken together with trailing twelve month EPS of...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Latest News In Cloud AI - Inriver's AI Platform Gains Microsoft Certified Software Designation

Inriver has achieved Microsoft Certified Software Designation for its AI-powered Product Information Management (PIM) platform, specifically designed for Manufacturing AI. Now available in the Microsoft Marketplace, this certification allows global Microsoft customers to discover and integrate Inriver’s solutions, enhancing innovation and business transformation through seamless compatibility with Microsoft products. The platform offers manufacturers enhanced capabilities for product data...
NYSE:ACN
NYSE:ACNIT

How Accenture’s Agentic AI Security and CX Bets At Accenture (ACN) Have Changed Its Investment Story

In recent weeks, Accenture, through Accenture Ventures, invested in XBOW’s autonomous cybersecurity testing platform and Netomi’s agentic customer experience AI, while also expanding an engineering collaboration with ServiceNow to embed agentic AI workflows directly into clients’ operations. Together, these moves deepen Accenture’s role at the center of AI-enabled enterprise reinvention, tying advanced security and customer-service agents into its broader transformation and managed-services...
NYSE:GOLF
NYSE:GOLFLeisure

Acushnet Holdings (GOLF) Is Down 7.5% After Profit Dip Despite Buybacks and New Product Sales - What's Changed

Acushnet Holdings Corp. reported first-quarter 2026 results, with sales rising to US$752.98 million while net income and earnings per share declined versus a year earlier. Over the same period, the company completed a multi-year buyback program totaling 19,275,829 shares for about US$1.02 billion, materially shrinking its share count. With revenue growth supported by new Titleist product launches but profits under pressure, we’ll examine how this shapes Acushnet’s investment narrative. The...
NasdaqGS:IBOC
NasdaqGS:IBOCBanks

Assessing International Bancshares (IBOC) Valuation After Strong First Quarter Earnings Update

Earnings event puts fresh focus on International Bancshares stock International Bancshares (IBOC) released first quarter 2026 results, reporting higher net interest income, net income and earnings per share compared with a year earlier. The update gives investors fresh numbers to assess the stock. See our latest analysis for International Bancshares. The earnings release comes after a period of mixed momentum, with a 7.37% 1 month share price return and a small 1.77% 3 month share price...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Gold.com (GOLD) Q3 Earnings Surge While Ultra Thin Margins Challenge Bullish Narratives

Gold.com (GOLD) just posted Q3 2026 results with revenue of about US$10.4b and net income of US$59.5m, equal to EPS of US$2.17, against a backdrop of 112.2% earnings growth over the past year and low net margins of around 0.3%. The company has seen quarterly revenue move from US$3.0b in Q3 2025 to US$10.4b in Q3 2026, while EPS shifted from a loss of US$0.36 to a profit of US$2.17 over the same periods, highlighting a combination of earnings momentum and thin margins for investors. See our...
NYSE:CBZ
NYSE:CBZProfessional Services

Assessing CBIZ (CBZ) Valuation After Solid Earnings, 2026 Outlook Reaffirmation And Ongoing Buybacks

Earnings and buybacks put CBIZ (CBZ) in focus CBIZ (CBZ) is back on investor radar after first quarter results, a reaffirmed 2026 revenue outlook of US$2.8b to US$2.9b, and ongoing share repurchases totaling millions of dollars. See our latest analysis for CBIZ. The stock has reacted quickly to the first quarter results and buyback activity, with a 1-day share price return of 6.74% and 1-month share price return of 12.31%. However, the recent 1-year total shareholder return of negative 56.37%...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource (BLDR) Valuation Check After Net Loss, Weaker Sales And Cut Earnings Estimates

Builders FirstSource (BLDR) is back in focus after reporting a first quarter net loss, along with lower sales and sharply reduced earnings estimates, developments that have weighed on sentiment toward the stock. See our latest analysis for Builders FirstSource. The latest earnings setback and weaker outlook have been reflected in the share price. The 90 day share price return of 36.18% and 1 year total shareholder return of 28.50% are both firmly negative, while the 5 year total shareholder...
NYSE:CWEN
NYSE:CWENRenewable Energy

Clearway Energy (CWEN) Valuation Check As Clean Power And Data Center Demand Narratives Gain Attention

What is moving Clearway Energy today With no single headline event driving trading, Clearway Energy (CWEN) is drawing attention as investors weigh its recent share performance and the company’s position in U.S. clean power generation and grid support. See our latest analysis for Clearway Energy. Recent trading has been softer, with a 7 day share price return of 5.5% and a 30 day share price return of 3.9%. However, a 12.3% year to date share price return and 40.1% 1 year total shareholder...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Reassessing Viridian Therapeutics (VRDN) After Volatile Share Price Swings

If you are wondering whether Viridian Therapeutics at around US$16.97 is priced for opportunity or risk, the key question is what that tag really says about the business. The stock has recently shown sharp moves, with returns of 25.9% over 7 days and 21.6% over 30 days, while year to date it is down 44.7% and up 32.8% over the past year. This mix of recent gains and earlier weakness has put valuation back in focus as investors reassess what they are willing to pay for Viridian Therapeutics...
NYSE:BK
NYSE:BKCapital Markets

How BNY’s UAE Crypto Custody Expansion At Bank of New York Mellon (BK) Has Changed Its Investment Story

In early May 2026, Bank of New York Mellon Corporation announced a partnership with Finstreet Limited and ADI Foundation to offer Bitcoin and Ethereum custody services in the UAE, with the intention of broadening coverage to regulated stablecoins, tokenized real-world assets, and other digital instruments over time. This move extends BNY’s existing digital asset capabilities into a jurisdiction aiming to be a global digital finance hub, highlighting how traditional custody infrastructure is...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Outlook And Filing Share Offering – Has The Bull Case Changed?

Inspire Medical Systems recently reported first-quarter 2026 results, with sales of US$204.58 million but a shift from net income to an US$11.29 million net loss, and subsequently filed a US$118.82 million shelf registration for 2,600,000 common shares tied to an ESOP-related offering. A key development for investors is the company’s revised 2026 outlook, which now calls for US$825 million to US$875 million in revenue, a 4% to 10% decline versus 2025, alongside expected diluted EPS of...